Skip to main content
. 2016 Apr 14;75(10):1006–1015. doi: 10.1007/s00393-016-0071-9

Table 1.

Summary of treatments

MTX O’Dell ADA combination therapy Associated HAQ change (normal dist) HAQ change STDDEV
ACR20 response (%) 31 28 58 −0.44266 0.01831
ACR50 response (%) 11 15 36 −0.66795 0.02610
ACR70 response (%) 4 7 19 −0.92257 0.03201
Duration shape parameter 0.51 0.49 0.73
Duration scale parameter 15.73 7.31 5.96
Direct treatment costs (Q1) 74.82 € 220.34 € 5,943.26 €
Direct treatment costs (Qn) 77.99 € 223.51 € 5,757.71 €